Call Our HELPLINE: 1-800-4PD-INFO (473-4636)

Parkinson's Disease Foundation to Host Celebrate Spring New York on Thursday, April 7

The Young New Yorkers for the Fight Against Parkinson’s and the Parkinson’s Disease Foundation® (PDF®) will hold its ninth annual Celebrate Spring New York at Marquee located at 289 10th Avenue between 26th and 27th Streets in New York City on Thursday, April 7, 2016.   Proceeds from the evening will support PDF’s research programs.

G. Pennington Egbert III, Gregory and Barbara Romero, Jonathan E. Romero, Jr., and Missy Egbert Sheehan and William B. Sheehan are the Co-Chairs.  W. Alexander Budney, Andrew S. Gustin, George and Peggy Hebard, Josh and Melissa Raskin, Adam and Kim Wolfberg, and Darren and Michele Wolfbergare the Vice-Chairs

Celebrate Spring New York was founded by G. Pennington Egbert III, his sister Missy Egbert Sheehan and their close friend Georgina B. Schaeffer whose fathers both lived with Parkinson’s disease.  They joined together to create the Young New Yorkers for the Fight Against Parkinson’s committee, a group of nearly 100 New Yorkers dedicated to advancing a cure for Parkinson’s.  Each year the committee hosts Celebrate Spring New York, which has raised nearly $675,000 since its inception.

The event will begin at 8:00 PM with cocktails, hors d’oeuvres, a live auction and dancing, with music provided by DJ Brenda Black. Support levels are as follows: sponsorships at $5,000, $2,500, $1,250, $500, $475 and $250 and individual tickets at $165.

The Parkinson’s Disease Foundation supports research and ideas that will improve the lives and futures of people touched by Parkinson’s.  Created by William Black, the founder of Chock full o’Nuts, a successful New York coffee and restaurant business, PDF was the first national not-for-profit organization to focus on Parkinson’s disease.  Since its founding in 1957, PDF has invested $110 million in the research of leading scientists around the world and an additional $47 million to support education and advocacy programs. 

Friday, March 18, 2016
Parkinson's Foundation Study Finds Gender Disparities in Caregiving, with Women at a Disadvantage
Monday, December 4, 2017

Largest Clinical Study Tracking Parkinson’s Patients Over Time Shows Women with Parkinson’s Have Fewer Caregiving Resources than Men with Parkinson’s

Parkinson’s Foundation Invests $60,000 to Develop Innovative Models of Patient Engagement
Wednesday, November 29, 2017

Six Awards Foster Patient-Driven Parkinson’s Research

Jesse Jackson Diagnosed with Parkinson's Disease
Friday, November 17, 2017

Rev. Jesse Jackson’s announcement today that he has been living with Parkinson’s Disease since 2015 further proves that receiving a diagnosis of Parkinson's is not a death sentence. There are many ways that people living with Parkinson's can control the symptoms of the disease with exercise and physical therapy to help maintain mobility and balance.

Update on Tozadenant Trial for Parkinson’s
Thursday, November 16, 2017

On 11/20/17, Acorda Therapeutics, Inc. announced that it is discontinuing the tozadenant clinical trial.  They concluded that they could not be confident that weekly white blood cell count screening would sufficiently ensure patient safety.

Parkinson’s Foundation Adds Marcia Mondavi Borger to Board of Directors
Tuesday, November 14, 2017

NEW YORK & MIAMI — The Parkinson’s Foundation today announced the election of Marcia Mondavi Borger to its Board of Directors.

Parkinson’s Foundation and Melvin Yahr International Parkinson’s Disease Foundation Announce Merger
Thursday, October 26, 2017

Parkinson’s Foundation Establishes ‘Dr. Melvin Yahr Research Award’ to Fund Neurology Fellows, Promote Leadership Diversity in Parkinson’s Research

Parkinson’s Foundation Welcomes Two New Board Members
Tuesday, October 24, 2017

Peter Goldman and Joshua Raskin Join Board of Directors

NEW YORK & MIAMI — The Parkinson’s Foundation today announced the election of Chicago entrepreneur Peter Goldman and New York financial analyst Joshua Raskin to its Board of Directors.

Parkinson's Foundation Unveils New Brand and Website
Thursday, October 19, 2017

NEW YORK and MIAMI /PRNewswire-USNewswire/ — The Parkinson's Foundation today announced the launch of its new brand and website following the recent merger of two legacy organizations – National Parkinson Foundation and Parkinson's Disease Foundation – as part of its mission to

FDA Approves Extended-Release Amantadine (GOCOVRI™) for Treatment of Dyskinesia
Friday, August 25, 2017

Statement from the Parkinson's Foundation Medical Director, Michael Okun, MD

Parkinson’s Foundation Announces $1.2 Million Investment to Advance Careers, Support Innovation of Early Career Parkinson’s Scientists
Tuesday, August 8, 2017

NEW YORK & MIAMI The Parkinson's Foundation is pleased to announce a $1.2 million investment in 27 career development and fellowship grants to support the work of promising early career scientists in the field of Parkinson's.

Pages

mail icon

Subscribe to get the latest news on treatments, research and other updates.